EXACT Therapeutics AS

OB:EXTX Stock Report

Market Cap: NOK 155.6m

EXACT Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of EXTX?
Owner TypeNumber of SharesOwnership Percentage
VC/PE Firms4,291,3166.78%
Institutions7,827,67212.4%
General Public8,973,80414.2%
Individual Insiders10,120,51116%
Private Companies14,541,87323%
Public Companies17,508,17127.7%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 97.2%.

Top Shareholders

Top 25 shareholders own 85.8% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
26.3%
GE HealthCare Technologies Inc.
16,647,956NOK 41.0m0%no data
9.65%
Investinor Direkte AS
6,105,522NOK 15.0m0%no data
6.78%
Canica AS
4,291,316NOK 10.6m0%0.04%
4.78%
Svein Kvåle
3,024,270NOK 7.4m0%no data
4.74%
Brekke Holding As
3,000,000NOK 7.4m0%no data
4.27%
Masha Paule Nathalie Stromme
2,699,842NOK 6.6m0%no data
4.25%
Helene Sundt AS
2,688,291NOK 6.6m0%no data
3.36%
Andrew Healey
2,123,885NOK 5.2m0%no data
2.88%
Per Sontum
1,824,595NOK 4.5m0%no data
2.76%
Optimuspistor As
1,745,464NOK 4.3m0%no data
1.99%
Goldman Sachs Group, Investment Banking and Securities Investments
1,255,956NOK 3.1m0%no data
1.97%
JPMorgan Chase & Co, Private Banking and Investment Banking Investments
1,244,999NOK 3.1m0%no data
1.84%
Kvantia AS
1,165,568NOK 2.9m0%1.06%
1.6%
DNB Asset Management AS
1,010,799NOK 2.5m0%no data
1.59%
T.D. VEEN AS
1,004,741NOK 2.5m0%0.49%
1.41%
CGS Holding AS
890,500NOK 2.2m0%no data
1.36%
Norda ASA
860,215NOK 2.1m0%no data
1.15%
P53 Invest AS
726,500NOK 1.8m0%100.0%
1.14%
Danske Invest Asset Management AS
719,109NOK 1.8m0%0.1%
1.11%
Blueberry Capital As
700,000NOK 1.7m0%31.79%
0.55%
William Castell
346,664NOK 852.8k0%no data
0.18%
Basen Capital As
112,096NOK 275.8k0%no data
0.12%
Anders Wold
72,924NOK 179.4k0%no data
0.017%
Per Walday
10,833NOK 26.6k0%no data
0.011%
John Edminson
6,666NOK 16.4k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/23 18:24
End of Day Share Price 2025/05/23 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

EXACT Therapeutics AS is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.